poisar

Stocks · News reference

Benzinga Bulls and Bears: Ross, Moderna, Webull

BenzingaBenzinga Senior Editor

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolRich Smith

    Why Webull Stock Dropped Today

    Webull stock fell 6.5% after the CFO's spouse sold 55,000 shares worth ~$494,000 on Monday. However, the analyst notes this shouldn't be concerning as the spouse still owns 772,046 shares and the sale likely relates to tax liability from recently acquired restricted stock units. The main concern remains the stock's steep valuation at 110x trailing earnings.

  2. The Motley FoolEric Volkman

    This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy?

    Stanley Druckenmiller's Duquesne family office has maintained Natera as its largest holding for 8 consecutive quarters. The medical diagnostics company uses liquid biopsy technology for cancer detection and other applications, showing strong growth with 57% year-over-year increase in oncology tests and 38% revenue growth. Despite persistent losses, the company has strong cash reserves and is projected to approach profitability by 2027. However, the stock has surged 87% in the past year with a lofty price-to-sales ratio of 17.